Grants Pass, OR â Portland News recognized venture capitalist and biotech innovator Andrew Hamilton as Oregonâs fastest growing biotech star, highlighting the rapid rise of his telehealth platform Vetr.com and the national acclaim it has received for excellence in digital design and communication. Vetr.com has been honored with some of the highest distinctions in the field this year. The platform earned the Platinum MarCom Award, which is the top honor in the MarCom international competition, and also received the New York Digital Award for Best Design, along with multiple Gold and Silver recognitions across related digital categories.
The MarCom Awards celebrate outstanding achievement in marketing and communications, with thousands of entries evaluated by industry professionals. The Platinum level is reserved for work that surpasses the competitionâs high standards and clearly stands out among all submissions. The New York Digital Awards also recognize innovation and exceptional performance across design, usability, and technical accomplishment.
Hamilton has built his reputation on developing solutions that expand real world access to animal health resources. One of his most notable contributions is ToltraMax, an over the counter toltrazuril oral solution that supports intestinal health in a wide range of animals. ToltraMax is formulated for dogs, cats, horses, and other non food chain animals, and offers caretakers a practical option for addressing parasitic concerns such as coccidia. The solution is widely recognized for its accessibility, broad application, and ease of use, which help caregivers respond quickly when issues arise. ToltraMax has earned trust in animal care settings because it supports multiple stages of the parasite life cycle and is suitable for diverse animal populations, from multi pet households to breeders and equine facilities.
Hamilton is also preparing for a significant milestone in his biotechnology work. He anticipates a second quarter 2026 drug approval for one of his upcoming treatments, a development that would affirm years of research, extensive formulation studies, and millions of dollars in investment. This expected approval would further strengthen his position within the animal drug sector and contribute to his growing influence in the broader biotech space. ToltraMax has already supported the health of countless animals, and Hamilton continues to demonstrate strong momentum as he advances new solutions that address urgent and widespread needs in animal care.
Vetrâs mission centers on bringing affordability and accessibility to veterinary services and essential care for pet owners across the country. The platform addresses long standing gaps in traditional access to veterinary care by offering virtual consultations with licensed professionals and by simplifying the process of obtaining trusted products, including ToltraMax. In addition to availability through Vetr.com, ToltraMax is distributed through major retail and animal health platforms that support both everyday and specialized caregiving environments.
The digital awards earned by Vetr reflect the organizationâs commitment to creating an intuitive and effective online experience that resonates with pet owners who seek reliable, easy to navigate solutions. Hamiltonâs leadership has guided Vetr from its beginnings toward a model that emphasizes practical biotechnology, everyday usability, and broad access to care. As Vetr continues to grow, the company is focused on expanding its reach and bringing innovative, dependable solutions to pet owners across the United States and eventually into international markets.
The recent awards align with a broader industry trend toward digital transformation in animal care. They also reinforce the importance of user centered design in creating tools that support informed decision making and timely action. Portland News highlights Hamiltonâs work as a significant contribution to this shift and as a defining example of the direction animal health innovation is heading.
For more information about Vetr and its award winning digital offerings, visit https://www.vetr.com.
About Vetr
Vetr is a telehealth platform and an FDA-registered drug manufacturer transforming pet healthcare by making veterinary services more affordable, accessible, and efficient. Through its user-friendly app, pet owners can schedule appointments, consult remotely with licensed veterinarians, and access low cost, over the counter animal prescriptions. Owned and founded by Andrew Hamilton, Vetr is dedicated to delivering high quality, cost effective care for pets nationwide and soon worldwide.
Media Contact:
Media Relations
sales@vetr.com
